Elevated cerebral blood flow and volume in systemic lupus measured by dynamic susceptibility contrast magnetic resonance imaging

Journal of Rheumatology

Volumn 37, Issue 9, 2010, Pages 1834-1843

  Gasparovic, Charles M ^a,b   Roldan, Carlos A ^a   Sibbitt Jr , Wilmer L ^a   Qualls, Clifford R ^a   Mullins, Paul G ^c   Sharrar, Janeen M ^a   Yamamoto, J Jeremy ^b   Bockholt, H Jeremy ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b MIND RESEARCH NETWORK   (United States)

^c BANGOR UNIVERSITY   (United Kingdom)

Author keywords

Brain; Cerebral blood flow; Cerebral blood volume; Lupus; Magnetic resonance imaging

Indexed keywords

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN PERFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DYNAMIC SUSCEPTIBILITY CONTRAST MAGNETIC RESONANCE IMAGING; FEMALE; GRAY MATTER; HUMAN; MALE; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; WHITE MATTER;

ADULT; BRAIN; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; REGIONAL BLOOD FLOW;

EID: 77956478013     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.091276     Document Type: Article

References (51)

1. Rhiannon JJ. Systemic lupus erythematosus involving the nervous system: presentation, pathogenesis, and management. Clin Rev Allergy Immunol 2008;34:356-60.
2. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. Rheumatology 2002;41:605-18.
3. Grunwald F, Schomburg A, Badali A, Ruhlmann J, Pavics L, Biersack HJ. 18FDG PET and acetazolamide-enhanced 99m Tc-HMPAO SPET in systemic lupus erythematosus. Eur J Nucl Med 1995;22:1073-7.
4. Otte A, Weiner SM, Peter HH, Mueller-Brand J, Goetze M, Moser E, et al. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study. Eur J Nucl Med 1997;24:787-91.
5. Sibbitt WL Jr, Haseler LJ, Griffey RR, Friedman SD, Brooks WM. Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy. AJNR Am J Neuroradiol 1997;18:1271-7.
6. Weiner SM, Otte A, Schumacher M, Klein R, Gutfleisch J, Brink I, et al. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis 2000;59:377-85.
7. Castellino G, Govoni M, Padovan M, Colamussi P, Borrelli M, Trotta F. Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up. Ann Rheum Dis 2005;64:1022-7.
8. Handa R, Sahota P, Kumar M, Jagannathan NR, Bal CS, Gulati M, et al. In vivo proton magnetic resonance spectroscopy (MRS) and single photon emission computerized tomography (SPECT) in systemic lupus erythematosus (SLE). Magn Reson Imaging 2003;21:1033-7.
9. Postiglione A, De Chiara S, Soricelli A, Oriente A, Ruocco A, Spadaro G, et al. Alterations of cerebral blood flow and antiphospholipid antibodies in patients with systemic lupus erythematosus. Int J Clin Lab Res 1998;28:34-8.
10. Huang JL, Yeh KW, You DL, Hsieh KH. Serial single photon emission computed tomography imaging in patients with cerebral lupus during acute exacerbation and after treatment. Pediatr Neurol 1997;17:44-8.
11. Waterloo K, Omdal R, Sjoholm H, Koldingsnes W, Jacobsen EA, Sundsfjord JA, et al. Neuropsychological dysfunction in systemic lupus erythematosus is not associated with changes in cerebral blood flow. J Neurol 2001;248:595-602.
12. Kobayashi H, Watanabe H, Seino T, Suzuki S, Sato Y. Quantitative imaging of cerebral blood flow using SPECT with 123I-iodoamphetamine in neuropsychiatric systemic lupus erythematosus. J Rheumatol 2003;30:2075-6.
13. Yoshida A, Shishido F, Kato K, Watanabe H, Seino O. Evaluation of cerebral perfusion in patients with neuropsychiatric systemic lupus erythematosus using 123I-IMP SPECT. Ann Nucl Med 2007;21:151-8.
14. Colamussi P, Trotta F, Ricci R, Cittanti C, Govoni M, Barbarella G, et al. Brain perfusion SPET and proton magnetic resonance spectroscopy in the evaluation of two systemic lupus erythematosus patients with mild neuropsychiatric manifestations. Nucl Med Commun 1997;18:269-73.
15. Emmi L, Bramati M, De Cristofaro MT, Mascalchi M, Dal Pozzo G, Marconi GP, et al. MRI and SPECT investigations of the CNS in SLE patients. Clin Exp Rheumatol 1993;11:13-20.
16. Kovacs JA, Urowitz MB, Gladman DD, Zeman R. The use of single photon emission computerized tomography in neuropsychiatric SLE: a pilot study. J Rheumatol 1995;22:1247-53.
17. Lin WY, Wang SJ, Yen TC, Lan JL. Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement. J Nucl Med 1997;38:1112-5.
18. Russo R, Gilday D, Laxer RM, Eddy A, Silverman ED. Single photon emission computed tomography scanning in childhood systemic lupus erythematosus. J Rheumatol 1998;25:576-82.
19. Sun SS, Huang WS, Chen JJ, Chang CP, Kao CH, Wang JJ. Evaluation of the effects of methylprednisolone pulse therapy in patients with systemic lupus erythematosus with brain involvement by Tc-99m HMPAO brain SPECT. Eur Radiol 2004;14:1311-5.
20. Pinching AJ, Travers RL, Hughes GR, Jones T, Moss S. Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus. Lancet 1978;1:898-900.
21. Volkow ND, Warner N, McIntyre R, Valentine A, Kulkarni M, Mullani N, et al. Cerebral involvement in systemic lupus erythematosus. Am J Physiol Imaging 1988;3:91-8.
22. Latchaw RE, Yonas H, Hunter GJ, Yuh WT, Ueda T, Sorensen AG, et al. Guidelines and recommendations for perfusion imaging in cerebral ischemia: A scientific statement for healthcare professionals by the writing group on perfusion imaging, from the Council on Cardiovascular Radiology of the American Heart Association. Stroke 2003;34:1084-104.
23. Ostergaard L. Principles of cerebral perfusion imaging by bolus tracking. J Magn Reson Imaging 2005;22:710-7.
24. Kuwabara Y, Sasaki M, Hirakata H, Koga H, Nakagawa M, Chen T, et al. Cerebral blood flow and vasodilatory capacity in anemia secondary to chronic renal failure. Kidney Int 2002;61:564-9.
25. Borrelli M, Tamarozzi R, Colamussi P, Govoni M, Trotta F, Lappi S. Evaluation with MR, perfusion MR and cerebral flow SPECT in NPSLE patients. Radiol Med 2003;105:482-9.
26. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
27. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
28. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
29. Rempp KA, Brix G, Wenz F, Becker CR, Guckel F, Lorenz WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994;193:637-41.
30. Wu O, Ostergaard L, Weisskoff RM, Benner T, Rosen BR, Sorensen AG. Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med 2003;50:164-74.
31. Magnotta VA, Bockholt HJ, Johnson HJ, Christensen GE, Andreasen NC. Subcortical, cerebellar, and magnetic resonance based consistent brain image registration. Neuroimage 2003;19:233-45.
32. Tanaka F, Vines D, Tsuchida T, Freedman M, Ichise M. Normal patterns on 99mTc-ECD brain SPECT scans in adults. J Nucl Med 2000;41:1456-64.
33. Speck O, Chang L, DeSilva NM, Ernst T. Perfusion MRI of the human brain with dynamic susceptibility contrast: gradient-echo versus spin-echo techniques. J Magn Reson Imaging 2000;12:381-7.
34. Wintermark M, Sesay M, Barbier E, Borbely K, Dillon WP, Eastwood JD, et al. Comparative overview of brain perfusion imaging techniques. J Neuroradiol 2005;32:294-314.
35. Lee PH, Joo US, Bang OY, Seo CH. Basal ganglia hyperperfusion in a patient with systemic lupus erythematosus-related parkinsonism. Neurology 2004;63:395-6.
36. Khubchandani RP, Viswanathan V, Desai J. Unusual neurologic manifestations (I): Parkinsonism in juvenile SLE. Lupus 2007;16:572-5.
37. Guadagno JV, Warburton EA, Jones PS, Fryer TD, Day DJ, Gillard JH, et al. The diffusion-weighted lesion in acute stroke: heterogeneous patterns of flow/metabolism uncoupling as assessed by quantitative positron emission tomography. Cerebrovasc Dis 2005;19:239-46.
38. Kim YS, Nur E, van Beers EJ, Truijen J, Davis SC, Biemond BJ, et al. Dynamic cerebral autoregulation in homozygous sickle cell disease. Stroke 2009;40:808-14.
39. Friberg L, Olsen TS. Cerebrovascular instability in a subset of patients with stroke and transient ischemic attack. Arch Neurol 1991;48:1026-31.
40. Sagiuchi T, Ishii K, Asano Y, Aoki Y, Kikuchi K, Jinguuji K, et al. Interictal crossed cerebellar hyperperfusion on Tc-99m ECD SPECT. Ann Nucl Med 2001;15:369-72.
41. Cruz J, Nakayama P, Imamura JH, Rosenfeld KG, de Souza HS, Giorgetti GV. Cerebral extraction of oxygen and intracranial hypertension in severe, acute, pediatric brain trauma: preliminary novel management strategies. Neurosurgery 2002;50:774-9.
42. Moore DF, Altarescu G, Herscovitch P, Schiffmann R. Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease. BMC Neurol 2002;2:4.
43. Pollock JM, Deibler AR, Burdette JH, Kraft RA, Tan H, Evans AB, et al. Migraine associated cerebral hyperperfusion with arterial spin-labeled MR imaging. AJNR Am J Neuroradiol 2008;29:1494-7.
44. Ge Y, Law M, Johnson G, Herbert J, Babb JS, Mannon LJ, et al. Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. AJNR Am J Neuroradiol 2005;26:1539-47.
45. Hatazawa J, Shimosegawa E, Toyoshima H, Ardekani BA, Suzuki A, Okudera T, et al. Cerebral blood volume in acute brain infarction: A combined study with dynamic susceptibility contrast MRI and 99mTc-HMPAO-SPECT. Stroke 1999;30:800-6.
46. Smith M. Perioperative uses of transcranial perfusion monitoring. Neurosurg Clin N Am 2008;19:489-502, vii.
47. Sibbitt WL Jr, Sibbitt RR, Brooks WM. Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1999;42:2026-38.
48. Kikuchi K, Murase K, Miki H, Kikuchi T, Sugawara Y, Mochizuki T, et al. Measurement of cerebral hemodynamics with perfusion-weighted MR imaging: comparison with pre- and post-acetazolamide 133Xe-SPECT in occlusive carotid disease. AJNR Am J Neuroradiol 2001;22:248-54.
49. Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007;242:647-9.
50. Calamante F, Gadian DG, Connelly A. Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke: assumptions, limitations, and potential implications for clinical use. Stroke 2002;33:1146-51.
51. Steup-Beekman G, Steens S, van Buchem M, Huizinga T. Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives. Lupus 2007;16:329-34.